Navigation Links
Sun burns treated with creams

Researchers observe that a new topical medication can effectively treat signs of aging due to repeated exposure to the sun. They found that in a long-term study of tazarotene cream, has successfully reduced fine wrinkling and mottled skin in more than 55 percent// of those tested, and it continued to show additional benefit as the length of use increased.

Ultraviolet radiation from the sun is known to have numerous ill effects on the skin, leading not only to the typical signs of aging, but also to skin cancer. Tazarotene has been shown in several studies to reduce these effects, but none have tested the treatment for longer than six months. These researchers measured the safety and effectiveness of the cream in a 25-week study, which was followed by an additional 26-week period in which participants were allowed to continue using the cream while being followed by the researchers.

In the first study period, about 573 subjects were assigned to receive either 0.15 percent tazarotene cream or treatment with a placebo cream for comparison purposes. All applied the creams on their faces once a day. Researchers then assessed each for various measures related to skin health. About 25 subjects in the tazarotene group dropped out due to skin irritation, compared to one in the placebo group. Blood levels of the medication, however, remained in the acceptable range.

After the initial 25-week period, all participants were offered the active treatment, and as of the one-year follow-up, the beneficial effects of the cream had yet to level off in the subjects. The authors write, "Efficacy was further improved with continued treatment and had not plateaued after 14 months, suggesting that additional efficacy may be achievable with longer-term treatment."


'"/>




Page: 1

Related medicine news :

1. Eating wrong foods may cause heartburns at night
2. Nervous disorder being treated
3. Acoustic neuroma in older patients to be treated
4. Rectal Cancer treated with radiation
5. Benign eye tumors being treated
6. Back pain treated with Opioids
7. Heart disease in women being under-treated
8. Adult COPD or asthma could be effectively treated with Xopenex
9. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
10. Untreated Scoliosis patients found to lead productive and active lives
11. Cardiac events better treated with intense cholesterol-lowering regime
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... CT (PRWEB) , ... October 13, 2017 , ... ... long-term care services, staged a mock evacuation of the facility as part of a ... Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: